Stock Comparison
ABBV vs SNY
AbbVie Inc and Sanofi ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$439.97B
$104.85B
P/E (TTM)
70.3
23.4
Forward P/E
17.7
8.6
Price/Sales
6.8
2.1
Price/Book
51.1
1.3
EV/EBITDA
25.8
8.4
Dividend Yield
2.03%
5.53%
Profitability
Net Margin
9.82%
15.95%
Operating Margin
29.77%
13.36%
Return on Equity
62.30%
5.71%
Return on Assets
10.50%
5.09%
Growth (YoY)
Revenue Growth
10.20%
14.60%
Earnings Growth
290.40%
-91.20%
Price & Risk
Beta
0.3
0.3
52-Week High
$263.65
$49.57
52-Week Low
$197.38
$41.29
Analyst Target
$274.36
$54.06
Compare ABBV and SNY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.